Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study

Overview of attention for article published in American Journal of Clinical Dermatology, May 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 1 news story.

217名の医師が参考になったと回答日本大学皮膚科研究所教授の照井正氏らは、局所療法で効果不十分な日本人の掌蹠膿疱症（PPP）患者90例を対象に、乾癬の治療に用いられるホスホジエステラーゼ（PDE）4阻害薬アプレミラストの有効性および安全性を第Ⅱ相二重盲検プ…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.